Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06363305 · ClinicalTrials.gov registry record · NA

Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health

A NA study of Hypertension and Pre Hypertension, sponsored by Skidmore College.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06363305 is a NA study of Hypertension and Pre Hypertension that is actively recruiting participants, run by Skidmore College. The registered enrollment target is 80 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06363305, a NA study of Hypertension and Pre Hypertension, is actively recruiting participants, sponsored by Skidmore College.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability, its effect on key markers of cardiovascular (CV) health, including BP, macro- and microvascular function, and arterial stiffness. This knowledge will provide critical insight into the effects of dietary capsaicin on CV health and will guide future trials.

Interventions

  • DIETARY_SUPPLEMENT Dietary capsules

Study Locations (1)

New York

  • Skidmore College - Saratoga Springs

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-07-08
Est. Completion 2025-12-31
Phase NA

Sponsor

Skidmore College

13 total trials

What the Registry Record Tells You About NCT06363305

The ClinicalTrials.gov registry entry for NCT06363305 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is Skidmore College, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Dietary capsules is the first listed.

NCT06363305 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06363305 about?

NCT06363305 is a clinical study titled "Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health". The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability...

What is the current status of trial NCT06363305?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-07-08. Estimated completion is 2025-12-31.

What conditions does trial NCT06363305 study?

This clinical trial studies the following conditions: Hypertension, Pre Hypertension.

What interventions are being tested in trial NCT06363305?

The interventions under investigation include: Dietary capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06363305?

This trial is sponsored by Skidmore College, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06363305 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.